Does Missouri Medicaid Cover Zepbound and Wegovy? MO HealthNet's GLP-1 Rules

Yes for Zepbound, no for Wegovy. As of November 2026, MO HealthNet, Missouri’s Medicaid program, covers Zepbound and the Foundayo pill for weight loss with prior authorization, for adults whose BMI reaches 30, or 27 when a related health problem is present.^[1][3] Wegovy is not covered for weight loss at all; it is approved only to lower heart risk or treat the liver disease MASH, in people with no diabetes.^[2]

Does Missouri Medicaid cover Zepbound for weight loss?

Yes. MO HealthNet used to leave weight-loss drugs out, an option states have under federal law, and its criteria document says so plainly before explaining why it began covering selected ones.^[1][5] Those criteria were first put in place on January 9, 2025.^[1] On the drug list effective November 1, 2026, the obesity class has three preferred products, Foundayo, Zepbound and the Zepbound KwikPen, and one non-preferred product, Wegovy.^[3] Any weight-loss drug not named in the policy stays excluded.^[1] For how other programs handle this drug, see our guide to Medicaid coverage of Zepbound by state.

Who qualifies for Zepbound or Foundayo through MO HealthNet?

The request must meet one of these routes, documented in the record:^[1][2]

Two features stand out. Current antipsychotic treatment is a route of its own, and the list of qualifying conditions includes type 2 diabetes and sleep apnea, so people with those conditions use the same weight route rather than a separate one.^[1] The age line also stands out: the criteria accept Zepbound claims from age 12, while the drug’s FDA label covers adults only.^[1][7] Foundayo is limited to adults, which matches its label.^[1][9] Our explainer on the BMI lines for Wegovy and Zepbound sets the state’s numbers against the labels.

People who started Zepbound before MO HealthNet covered it must send the BMI at the start of treatment as well as today, how they paid, and the three most recent fill dates.^[2] The default approval period in the criteria is 90 days, and a second GLP-1 at the same time is denied.^[1] Our page on Foundayo, the daily orforglipron pill covers the newer preferred option.

When will MO HealthNet pay for Wegovy?

Only for two uses, and never for weight loss: the form says Wegovy for reducing or keeping off excess weight “is not covered by MO HealthNet.”^[2] Both remaining routes require proof that the person does not have diabetes: an A1C under 6.5 from the past three months and no diabetes diagnosis or diabetes medicine in the past two years.^[1]

The approvals come in short steps. The first lasts four weeks, and each dose during titration needs its own four-week approval until the patient reaches at least 1.7 mg; one extra four weeks at a dose may be approved once, with documented side effects the patient could not tolerate.^[1][2] A patient who cannot reach 1.7 mg within six months is denied.^[1] Wegovy’s label allows the heart use in any adult, so the age-45 line is the state’s own.^[8] Our page on GLP-1 treatment for MASH explains the liver evidence.

Does MO HealthNet cover Ozempic and Mounjaro for diabetes?

Yes, with a diabetes diagnosis. Mounjaro, the Ozempic injection, Trulicity and Victoza are preferred on the November 2026 list; the non-preferred ones include generic liraglutide, exenatide, Rybelsus and the Ozempic tablet.^[3] A non-preferred diabetes GLP-1 needs trials of three preferred drugs for three months each, with notes on why each was stopped, and the form asks about a metformin trial.^[2] The April form lists Byetta as preferred while the November list shows it as non-preferred, so check the current list for that drug.^[2][3]

How do you file, and does your health plan matter?

Your health plan does not change the drug rules. Missouri carves pharmacy out of managed care and pays it through fee-for-service, so members of Healthy Blue, Home State Health, UnitedHealthcare and Show Me Healthy Kids all use the state’s criteria.^[4] The prescriber sends Form 2575-053 by fax to (573) 636-6470, and drug-specific questions go to (800) 392-8030.^[2] The form warns that a request missing information will not be processed.^[2]

How do you appeal a MO HealthNet denial?

Check whether the denial is about the drug or the paperwork. Asking for Wegovy for weight loss cannot succeed, because the program excludes it, but the same patient may qualify for Zepbound.^[2][1] A missing A1C, BMI date or fill history is a records problem that can be fixed by refiling.^[2]

Because pharmacy is handled by the state program, a formal appeal is a request for a state fair hearing. Federal rules cap the time a state may allow for that request at 90 days from the date the notice is mailed, so use the date printed on your notice.^[6] Our walkthrough of prior authorization and appeals covers what to send, and the Missouri state page keeps the basics together.

What if MO HealthNet will not pay?

Cash is the fallback, and Lilly’s savings card excludes Medicaid members.^[10] Novo Nordisk’s self-pay price for most Wegovy pen doses is $349 a month, and Lilly’s Zepbound KwikPen costs $299 at the starting dose, $399 at 5 mg and $449 at higher doses refilled within 45 days.^[10][11] Check each program’s rules for government coverage first. Our list of the cheapest GLP-1 options without insurance compares them.